Brief: Athira Pharma Inc Reports Quarterly Net Loss Of $20.2 Million, Or $0.53 Per Share

LeonaBio

10/11/2022 21:56

Nov 10 (Reuters) - Athira Pharma Inc  ATHA.O :
    * ATHIRA PHARMA REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
AND
RECENT CLINICAL AND CORPORATE UPDATES
    * QTRLY NET LOSS OF $20.2 MILLION, OR $0.53 PER SHARE
    * CASH, CASH EQUIVALENTS AND INVESTMENTS WERE $260.0 MILLION
AS OF
SEPTEMBER 30, 2022
    * Q3 EARNINGS PER SHARE VIEW $-0.63 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6SQSmf 
Further company coverage:  ATHA.O 
 ((Reuters.Briefs@thomsonreuters.com;;))